Chemotherapy (unspecified agents)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Chemotherapy (unspecified agents), covering 2012-06-12 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy [Phase 2]